Advanced

How can the business benefit of Business Continuity Planning be measured? -A case study at AstraZeneca

Degerfalk, Lisa and Larsson, Mattias (2006) In LUTVDG/TVBB--5212--SE VBR920
Division of Fire Safety Engineering
Risk Management and Safety Engineering (M.Sc.Eng.)
Division of Risk Management and Societal Safety
Abstract
This thesis treats the area of Business Continuity Planning (BCP), which is one way to decrease the vulnerability in an organization. The main objective was to investigate how the business benefit of BCP could be measured in monetary terms. The aim of this investigation was the development of a general and practically usable framework. The framework was developed in a deductive way by combining theory about BCP, risk, decision making, and investment valuation. The framework is a five step work process that results in a ranking of the risk reducing investments based on their calculated Risk Adjusted Net Present Value (RANPV). The BCP process generates risk reducing investment alternatives that can be valuated with the framework. The thesis... (More)
This thesis treats the area of Business Continuity Planning (BCP), which is one way to decrease the vulnerability in an organization. The main objective was to investigate how the business benefit of BCP could be measured in monetary terms. The aim of this investigation was the development of a general and practically usable framework. The framework was developed in a deductive way by combining theory about BCP, risk, decision making, and investment valuation. The framework is a five step work process that results in a ranking of the risk reducing investments based on their calculated Risk Adjusted Net Present Value (RANPV). The BCP process generates risk reducing investment alternatives that can be valuated with the framework. The thesis has been performed in cooperation with AstraZeneca where a case study was carried out to test the practical usability of the framework. This thesis showed that the developed framework is general, practically usable and can measure the business benefit of BCP in monetary terms if the requirements of the user of the framework are met. (Less)
Please use this url to cite or link to this publication:
author
Degerfalk, Lisa and Larsson, Mattias
supervisor
organization
course
VBR920
year
type
H2 - Master's Degree (Two Years)
subject
keywords
AstraZeneca, Business Continuity Planning (BCP), Business benefit, Decision making, Net Present Value (NPV), Risk Adjusted Net Present Values (RANPV), Risk reducing investment alternative
publication/series
LUTVDG/TVBB--5212--SE
report number
5212
ISSN
1402-3504
language
English
id
1688970
date added to LUP
2011-01-20 17:00:32
date last changed
2014-03-10 10:40:34
@misc{1688970,
  abstract     = {This thesis treats the area of Business Continuity Planning (BCP), which is one way to decrease the vulnerability in an organization. The main objective was to investigate how the business benefit of BCP could be measured in monetary terms. The aim of this investigation was the development of a general and practically usable framework. The framework was developed in a deductive way by combining theory about BCP, risk, decision making, and investment valuation. The framework is a five step work process that results in a ranking of the risk reducing investments based on their calculated Risk Adjusted Net Present Value (RANPV). The BCP process generates risk reducing investment alternatives that can be valuated with the framework. The thesis has been performed in cooperation with AstraZeneca where a case study was carried out to test the practical usability of the framework. This thesis showed that the developed framework is general, practically usable and can measure the business benefit of BCP in monetary terms if the requirements of the user of the framework are met.},
  author       = {Degerfalk, Lisa and Larsson, Mattias},
  issn         = {1402-3504},
  keyword      = {AstraZeneca,Business Continuity Planning (BCP),Business benefit,Decision making,Net Present Value (NPV),Risk Adjusted Net Present Values (RANPV),Risk reducing investment alternative},
  language     = {eng},
  note         = {Student Paper},
  series       = {LUTVDG/TVBB--5212--SE},
  title        = {How can the business benefit of Business Continuity Planning be measured? -A case study at AstraZeneca},
  year         = {2006},
}